Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | Single-cell multiomics analysis and the role of PHF19 expression in high-risk multiple myeloma

Travis Johnson • 26 Aug 2022
IMS 2022
Multiple Myeloma

Travis Johnson, PhD, MS, Indiana University School of Medicine, Indianapolis, IN, shares some insights into a single-cell multiomics study which investigated the mechanisms behind high-risk myeloma, drawing focus on the role of PHF19 expression. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Travis Johnson

0:57
The potential of the TSAFinder tool in hematological oncology
Travis Johnson • 26 Aug 2022

Related Videos

1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
The content of VJHemOnc is intended for healthcare professionals